ANALYSIS · 2026-06-03 · CHINA · MACROECONOMICS

China's Life Expectancy: A Century of Gains in Six Decades

From 35 years in 1960 to nearly 78 years today, China's life expectancy trajectory is one of the most dramatic public health stories of the modern era.

By Meridian Intelligence Team 4 MIN READ

From 35 to 78: The Scale of the Transformation

In 1960, a child born in China could expect to live roughly 35 years — a figure shaped by famine, infectious disease, and limited medical infrastructure. By 2023, that number had climbed to 77.95 years. That is a gain of more than 40 years of life expectancy within a single human lifetime, a pace of improvement that few countries of any income level have matched over the same period.

For context, many high-income nations that already had life expectancies in the 60s and 70s during the 1960s have added only 10 to 15 years since then. China’s trajectory is not simply a story of catching up — it is a story of compressing what took wealthier nations a century into roughly six decades.

What the Most Recent Data Show

The latest available figures from Our World in Data reveal a small but notable dip in the most recent year on record. In 2022, China’s life expectancy at birth stood at 78.20 years. By 2023, that figure had edged down to 77.95 years — a decline of roughly 0.25 years between the two periods.

A drop of that magnitude is modest in absolute terms, but it is worth watching. Life expectancy at the national level is a lagging, smoothed indicator; small reversals often reflect real disruptions in mortality patterns, whether from disease burden, demographic shifts, or healthcare system stress. The 2022–2023 movement follows a period of significant public health disruption globally, and China was not insulated from those pressures.

Still, 77.95 years remains a historically high figure for China and places the country within range of several European nations that have long been considered benchmarks for population health.

The Drivers Behind the Long Climb

No single policy or intervention explains a 40-year gain in life expectancy. The data reflect the cumulative effect of several overlapping forces:

Reduction in infant and child mortality. Early gains in life expectancy are disproportionately driven by keeping children alive through their first years. Expanded vaccination programs, improved sanitation, and broader access to basic medical care during the latter half of the twentieth century dramatically reduced deaths among the youngest cohort.

Nutritional improvements. As agricultural output stabilized and food distribution improved, chronic undernutrition — a significant drag on life expectancy — declined substantially across rural and urban populations alike.

Urbanization and healthcare access. The movement of hundreds of millions of people into cities brought them closer to hospitals, clinics, and trained medical personnel. Urban populations in China have historically had higher life expectancies than rural ones, and the urbanization rate has risen sharply since the 1980s.

Control of infectious disease. Tuberculosis, cholera, and other communicable diseases that once claimed large numbers of lives have been brought under much tighter control through public health campaigns and improved living conditions.

Rising incomes. Economic growth since the late 1970s has raised household incomes, enabling better nutrition, housing, and access to private healthcare — all of which correlate strongly with longer lives.

Where the Ceiling Might Be

At 77.95 years, China is approaching the range where further gains become harder to achieve. The leading causes of death in high-longevity populations shift from infectious and nutritional diseases — which are relatively tractable — to cardiovascular disease, cancer, and neurological conditions, which are more complex and expensive to address.

China’s aging population adds another layer of complexity. As the share of elderly citizens grows, the aggregate burden of age-related illness increases, and sustaining or improving life expectancy requires ever-greater investment in geriatric care, chronic disease management, and long-term support systems.

The 2022-to-2023 dip from 78.20 years to 77.95 years may prove to be a temporary fluctuation rather than a structural reversal. But it serves as a reminder that life expectancy gains are not automatic or irreversible. They require sustained institutional commitment.

A Benchmark Worth Studying

China’s experience offers a data point that demographers and public health researchers continue to examine closely. The speed of the gain — from a pre-industrial baseline to near-developed-world levels within living memory — challenges assumptions about how quickly population health can change when economic development, public health infrastructure, and political prioritization align.

The figure of 77.95 years in 2023 is not just a statistic. It represents the cumulative outcome of decisions made across generations: about food, medicine, infrastructure, and governance. Whether the next decade adds to that number or sees further small retreats will depend on how effectively China manages the transition from a country fighting early-life mortality to one managing the chronic burdens of an older, longer-lived population.


Source: Our World in Data. Licensed under CC BY 4.0.

Disclaimer: This post is generated from public datasets for informational purposes only and does not constitute financial, legal, medical, or professional advice. Figures reflect the source dataset as fetched on the date shown above and may have been updated since. Meridian Intelligence makes no warranty as to accuracy or fitness for a particular purpose.

Every figure above is traced to a source row. How we validate our data · Editorial standards

Related analyses